Paper36087307
Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.
Janelidze S and 16 others. Brain, 2023. Cited by 442 papers, by iCite.
Cite this record
ConductScience Library. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease. Papers, record 36087307. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36087307
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Cognitive Dysfunction | Major topic |
| Humans | |
| Female | |
| Aged | |
| Male | |
| tau Proteins | |
| Amyloid beta-Peptides | |
| Brain | |
| Biomarkers |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 NS095773 | NINDS NIH HHS | United States | R01NS095773 | PubMed and NIH | NIH RePORTER |
| R01 AG068398 | NIA NIH HHS | United States | R01AG068398 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06547099 | Study to Understand Novel Biomarkers in Researching Dementia | Background |
Source ClinicalTrials.gov
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20157306 | Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. | Nat Rev Neurol | 2010 | https://conductscience.org/library/papers/20157306 | PubMed |
| 2 | 34353941 | Phenotyping Alzheimer's disease with blood tests. | Science | 2021 | https://conductscience.org/library/papers/34353941 | PubMed |
| 3 | 32123386 | Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration. | Nat Med | 2020 | https://conductscience.org/library/papers/32123386 | PubMed |
| 4 | 34031605 | Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures. | Nat Med | 2021 | https://conductscience.org/library/papers/34031605 | PubMed |
| 5 | 21414208 | pROC: an open-source package for R and S+ to analyze and compare ROC curves. | BMC Bioinformatics | 2011 | https://conductscience.org/library/papers/21414208 | PubMed |
| 6 | 34859598 | Blood-based biomarkers for Alzheimer's disease. | EMBO Mol Med | 2022 | https://conductscience.org/library/papers/34859598 | PubMed |
| 7 | 32183883 | Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification. | Alzheimers Res Ther | 2020 | https://conductscience.org/library/papers/32183883 | PubMed |
| 8 | 35195758 | Plasma biomarkers for Alzheimer's Disease in relation to neuropathology and cognitive change. | Acta Neuropathol | 2022 | https://conductscience.org/library/papers/35195758 | PubMed |
| 9 | 26921134 | Alzheimer's disease. | Lancet | 2016 | https://conductscience.org/library/papers/26921134 | PubMed |
| 10 | 25840462 | Amyloid biomarkers in Alzheimer's disease. | Trends Pharmacol Sci | 2015 | https://conductscience.org/library/papers/25840462 | PubMed |
| 11 | 33585983 | Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology. | Acta Neuropathol | 2021 | https://conductscience.org/library/papers/33585983 | PubMed |
| 12 | 34083813 | Biomarkers for neurodegenerative diseases. | Nat Med | 2021 | https://conductscience.org/library/papers/34083813 | PubMed |
| 13 | 34542571 | Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease. | JAMA Neurol | 2021 | https://conductscience.org/library/papers/34542571 | PubMed |
| 14 | 32725127 | Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer's disease. | J Exp Med | 2020 | https://conductscience.org/library/papers/32725127 | PubMed |
| 15 | 33773595 | Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment. | Alzheimers Res Ther | 2021 | https://conductscience.org/library/papers/33773595 | PubMed |
| 16 | 32722745 | Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. | JAMA | 2020 | https://conductscience.org/library/papers/32722745 | PubMed |
| 17 | 35643092 | Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials. | Lancet Neurol | 2022 | https://conductscience.org/library/papers/35643092 | PubMed |
| 18 | 15324362 | Mild cognitive impairment as a diagnostic entity. | J Intern Med | 2004 | https://conductscience.org/library/papers/15324362 | PubMed |
| 19 | 34309632 | Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes. | JAMA Neurol | 2021 | https://conductscience.org/library/papers/34309632 | PubMed |
| 20 | 34095436 | Development and validation of a high-sensitivity assay for measuring p217+tau in plasma. | Alzheimers Dement (Amst) | 2021 | https://conductscience.org/library/papers/34095436 | PubMed |
Cited by346
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 442 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985795 | Deep Learning for AD Risk Screening and Progression Prediction. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42985795 | PubMed |
| 42979019 | Multi-platform comparison of plasma phosphorylated tau assays: analytical and workflow factors drive clinical implementation decisions. | Alzheimers Dement (Amst) | 2026 | https://conductscience.org/library/papers/42979019 | PubMed |
| 42947225 | Short-interval variability and test-retest reliability of Alzheimer's disease plasma biomarkers in a clinically heterogenous cohort. | Alzheimers Res Ther | 2026 | https://conductscience.org/library/papers/42947225 | PubMed |
| 42921107 | Evaluation of harmonization methods to mitigate assay and cohort effects in plasma p-tau217. | Alzheimers Dement (Amst) | 2026 | https://conductscience.org/library/papers/42921107 | PubMed |
| 42913444 | Blood-Based Biomarkers as Predictors of All-Cause Dementia: A 13-Year Follow-Up in the Whitehall II Cohort Study. | Neurology | 2026 | https://conductscience.org/library/papers/42913444 | PubMed |
| 42909513 | APOE ε4 accelerates plasma p-tau217 trajectory: a Bayesian joint longitudinal analysis of ADNI. | Neurol Sci | 2026 | https://conductscience.org/library/papers/42909513 | PubMed |
| 42905283 | Clinical performance and decision thresholds of an automated plasma p-tau217 assay for amyloid pathology in a Taiwanese memory clinic. | J Neurol | 2026 | https://conductscience.org/library/papers/42905283 | PubMed |
| 42889489 | Comparison of brain-derived versus conventional pTau biomarkers in CSF and plasma for detecting Alzheimer's disease. | Brain Commun | 2026 | https://conductscience.org/library/papers/42889489 | PubMed |
| 42876932 | Low premorbid IQ effects biomarker-cognition relationships: A pilot study. | J Alzheimers Dis Rep | 2026 | https://conductscience.org/library/papers/42876932 | PubMed |
| 42865723 | Plasma biomarker strategies to reduce diagnostic uncertainty in p-tau217-based assessment of CSF amyloid positivity in secondary-care patients with MCI. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42865723 | PubMed |
| 42837647 | Quantitative Relationship Between Lumipulse G Measures of pTau217 in Plasma and the Temporal Cortex. | Neurology | 2026 | https://conductscience.org/library/papers/42837647 | PubMed |
| 42832237 | Earlier Disclosure of Blood-Based Biomarkers, Diagnostic Certainty, and Clinical Management: A Randomized Clinical Trial. | JAMA Neurol | 2026 | https://conductscience.org/library/papers/42832237 | PubMed |
| 42821845 | Clinical Factors Associated With Discordant Plasma P-Tau217 and Established Alzheimer Disease Biomarkers. | Neurology | 2026 | https://conductscience.org/library/papers/42821845 | PubMed |
| 42799937 | Motor speech markers of Alzheimer's risk. | Geroscience | 2026 | https://conductscience.org/library/papers/42799937 | PubMed |
| 42780170 | Epitope placement tunes CSF tau biomarkers: Comparison of P-tau217 and BD-tau designs. | Mol Neurodegener Adv | 2026 | https://conductscience.org/library/papers/42780170 | PubMed |
| 42745326 | Enhancing Alzheimer's disease diagnosis in primary care through targeted screening of people at risk of developing dementia - study design and feasibility assessment of the PREDEM primary care study. | Alzheimers Res Ther | 2026 | https://conductscience.org/library/papers/42745326 | PubMed |
| 42733037 | Cerebral oxygen extraction fraction as a physiological biomarker in vascular cognitive impairment: A study in older adults enriched for small vessel diseases. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42733037 | PubMed |
| 42719535 | Elecsys pT181p immunoassay: Clinical performance for ruling out amyloid pathology. | Alzheimers Dement (Amst) | 2026 | https://conductscience.org/library/papers/42719535 | PubMed |
| 42698737 | Translating blood-based biomarkers into Alzheimer's disease clinical practice: screening, diagnosis, and longitudinal monitoring. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42698737 | PubMed |
| 42694243 | Blood-based biomarkers of Alzheimer's disease and neurodegeneration in an indigenous African cohort using both Simoa and NULISA platforms. | NPJ Dement | 2026 | https://conductscience.org/library/papers/42694243 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOE | 348 | PubTator's text mining | https://conductscience.org/library/genes/348 | NCBI Gene |
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36087307
GET https://conductscience.org/api/papers/v1/36087307/references?page=2